Mayur Ian Somaiya

NAMS

Mayur Ian Somaiya serves as Chief Financial Officer at NewAmsterdam Pharma Company N.V. (NAMS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$170.2K

Net Position

Net Seller

$170.2K

Companies Traded

NAMS

Active Period

Jan 2026

1 total trades

Most Recent

Sell NAMS

Jan 5, 2026 · $170.2K

Mayur Ian Somaiya's Insider Trading at NewAmsterdam Pharma Company N.V. (NAMS)

Buys

0 · $0.00

Sells

1 · $170.2K

Total Shares Bought

Total Shares Sold

5,118

NAMS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026↗	Sell	5,118	$33.25	$170.2K	0

Related Insiders

Johannes Jacob Pieter Kastelein

CTO

NAMSSell · Feb 20, 2026

Louise Frederika Kooij

Chief Accounting Officer

NAMSSell · Jan 26, 2026

Michael H. Davidson

Chief Executive Officer

NAMSSell · Jan 7, 2026

James N Topper

Director

NAMSBuy · Sep 15, 2025

Douglas F Kling

Chief Operating Officer

NAMSSell · May 15, 2025

Explore More Insider Trading Data

NAMS Insider Trading Activity

View all insider trades at NewAmsterdam Pharma Company N.V.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity